Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05671887 · ClinicalTrials.gov registry record
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
A clinical trial of Lung Cancer and Lung Transplant, sponsored by Northwestern University.
- Recruiting
- Registry status
- 125
- Enrollment target
- 1
- Study location
NCT05671887: Recruiting study of Lung Cancer and Lung Transplant, sponsored by Northwestern University.
NCT05671887 is a study of Lung Cancer and Lung Transplant that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 125 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05671887, a study of Lung Cancer and Lung Transplant, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational registration trial for patients who undergo lung transplantation for the treatment of the select groups of medically refractory cancers affecting the lungs alone without extrapulmonary nodal and distant metastasis.
Conditions Studied
Interventions
- PROCEDURE Double Lung Transplantation
Study Locations (1)
Illinois
- Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital) - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2022-11-16 |
| Est. Completion | 2032-11 |
What NCT05671887 shows while recruiting
NCT05671887 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Double Lung Transplantation is the first listed.
NCT05671887 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05671887 about?
NCT05671887 is a clinical study titled "DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies". This is a prospective observational registration trial for patients who undergo lung transplantation for the treatment of the select groups of medically refractory cancers affecting the lungs alone without extrapulmonary nodal and distant metastasis.
What is the current status of trial NCT05671887?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2022-11-16. Estimated completion is 2032-11.
What conditions does trial NCT05671887 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Transplant, Bilateral Cancer.
What interventions are being tested in trial NCT05671887?
The interventions under investigation include: Double Lung Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT05671887?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05671887 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05671887's enrollment target sits among peer trials
125 165th of 409 higher than 243 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI